ConductScience.org, home

Paper41001338

Pharmacovigilance practice on off-label high-dose of vancomycin in severely ill children.

Qin M and 3 others. Front Pharmacol, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Pharmacovigilance practice on off-label high-dose of vancomycin in severely ill children. Papers, record 41001338. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41001338

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacovigilance practice on off-label high-dose of vancomycin in severely ill children.
PubMed
Journal
Front Pharmacol
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-09-28
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Qin MMin
2Chen WWenwen
3Lu BBin
4Deng YYi

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132242356Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012-2017.N Engl J Med2020https://conductscience.org/library/papers/32242356PubMed
212741439Mississippi mud no more: cost-effectiveness of pharmacokinetic dosage adjustment of vancomycin to prevent nephrotoxicity.Pharmacotherapy2003https://conductscience.org/library/papers/12741439PubMed
334750740Pharmacokinetics of Vancomycin in Critically Ill Children: A Systematic Review.Eur J Drug Metab Pharmacokinet2022https://conductscience.org/library/papers/34750740PubMed
433839974Dosing Recommendations for Vancomycin in Children and Adolescents with Varying Levels of Obesity and Renal Dysfunction: a Population Pharmacokinetic Study in 1892 Children Aged 1-18 Years.AAPS J2021https://conductscience.org/library/papers/33839974PubMed
522411630Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review.Eur J Clin Pharmacol2012https://conductscience.org/library/papers/22411630PubMed
630833429Revising Pediatric Vancomycin Dosing Accounting for Nephrotoxicity in a Pharmacokinetic-Pharmacodynamic Model.Antimicrob Agents Chemother2019https://conductscience.org/library/papers/30833429PubMed
727585904Clinical Pharmacology Studies in Critically Ill Children.Pharm Res2017https://conductscience.org/library/papers/27585904PubMed
832191793
Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
Am J Health Syst Pharm2020https://conductscience.org/library/papers/32191793PubMed
930216124Guideline for the Management of Clostridium Difficile Infection in Children and Adolescents With Cancer and Pediatric Hematopoietic Stem-Cell Transplantation Recipients.J Clin Oncol2018https://conductscience.org/library/papers/30216124PubMed
1033161460Baseline kidney function is associated with vancomycin-induced acute kidney injury in children: a prospective nested case-control study.Pediatr Nephrol2021https://conductscience.org/library/papers/33161460PubMed
1131935538Correlation of the vancomycin 24-h area under the concentration-time curve (AUC24) and trough serum concentration in children with severe infection: A clinical pharmacokinetic study.Int J Infect Dis2020https://conductscience.org/library/papers/31935538PubMed
1231378957Vancomycin is commonly under-dosed in critically ill children and neonates.Br J Clin Pharmacol2019https://conductscience.org/library/papers/31378957PubMed
1324515100Dosing in children: a critical review of the pharmacokinetic allometric scaling and modelling approaches in paediatric drug development and clinical settings.Clin Pharmacokinet2014https://conductscience.org/library/papers/24515100PubMed
1434233034Children may need higher vancomycin doses to achieve therapeutic levels.Acta Paediatr2021https://conductscience.org/library/papers/34233034PubMed
1524315788Area under the concentration-time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia.Int J Antimicrob Agents2014https://conductscience.org/library/papers/24315788PubMed
1628973124Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.JAMA Pediatr2017https://conductscience.org/library/papers/28973124PubMed
1731301023Clinical Pharmacokinetics of Vancomycin in Critically Ill Children.Eur J Drug Metab Pharmacokinet2019https://conductscience.org/library/papers/31301023PubMed
1821208910Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.Clin Infect Dis2011https://conductscience.org/library/papers/21208910PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41001338

GET https://conductscience.org/api/papers/v1/41001338/authors